Microarray analysis is basically a laboratory device that is used to detect the expression of multiple (thousands) genes simultaneously. The DNA microarrays are nothing but the microscopic slides printed with multiple tiny spots in pre-defined positions. Here, every point contains a known DNA gene or the sequence. Mostly, these slides are referred as DN chips or the gene chips. The DNA molecules connected to every slide play a major role as a tool to detect gene expression. This is also called as the set of messenger or transcriptome RNA (nRNA) records expressed by the gene groups. To execute a microarray study, the mRNA molecules are usually collected from both reference sample and the experimental sample.
Microarray analysis market was estimated to be over US$ 3.7 Billion in 2018. It is anticipated to grow at a CAGR of 7.1% from 2019 to 2030.
The continual growth of the microarray analysis market can be attributed to several factors which have led to wide scale adoption of these devices which are extensively used to study the diverse number of biological processes. Moreover, the growing demand for microarray across the globe is anticipated to further contribute to the substantial growth of the global microarray analysis market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. The National institute for Biomedical Genomics, a publicly funded national institution based in India, has entered into an agreement with Department of Biotechnology, Government of India and Global Alliance for Genomics and Health to share health and genomic related data.
Major Key Players of the Microarray Analysis Market are:
Thermo Fisher Scientific, Agilent Technologies, Molecular Devices, PerkinElmer, Illumina, GE Healthcare, and Bio-Rad Laboratories, Merck KGaA, Arrayit Corporation, Microarrays, Inc. Among others.
No comments:
Post a Comment